The strong supporting evidence from Clinical Validity Framework of ClinGen and evidence from four of five clinical‐genetic aspects suggested the association between CHD4 variants and epilepsy, suggesting that CHD4 mutations are potentially a candidate pathogenic gene of epilepsy with sinus arrhythmia. The gene discussed is CHD4; the disease is epilepsy.